Quest Diagnostics Incorporated (DGX) - Cash Flow Conversion Efficiency
Based on the latest financial reports, Quest Diagnostics Incorporated (DGX) has a cash flow conversion efficiency ratio of 0.064x as of December 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow ($465.00 Million) by net assets ($7.29 Billion). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.
Quest Diagnostics Incorporated - Cash Flow Conversion Efficiency Trend (1996–2025)
This chart illustrates how Quest Diagnostics Incorporated's cash flow conversion efficiency has evolved over time, based on yearly financial data. Read DGX total liabilities for a breakdown of total debt and financial obligations.
Quest Diagnostics Incorporated Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Quest Diagnostics Incorporated ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
International Flavors & Fragrances Inc
NYSE:IFF
|
0.022x |
|
Telia Company AB
ST:TELIA
|
0.136x |
|
Global Unichip Corp
TW:3443
|
-0.021x |
|
First Solar Inc
NASDAQ:FSLR
|
0.130x |
|
Valterra Platinum Limited
JSE:VAL
|
0.264x |
|
KUAISHOU TECHNOLOGY CL.B
F:5Y0
|
N/A |
|
Bank of Nanjing Co Ltd
SHG:601009
|
-0.257x |
|
SoFi Technologies Inc.
NASDAQ:SOFI
|
-0.094x |
Annual Cash Flow Conversion Efficiency for Quest Diagnostics Incorporated (1996–2025)
The table below shows the annual cash flow conversion efficiency of Quest Diagnostics Incorporated from 1996 to 2025. For the full company profile with market capitalisation and key ratios, see Quest Diagnostics Incorporated (DGX) total market value.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2025-12-31 | $7.29 Billion | $1.89 Billion | 0.259x | +33.81% |
| 2024-12-31 | $6.90 Billion | $1.33 Billion | 0.193x | -2.40% |
| 2023-12-31 | $6.42 Billion | $1.27 Billion | 0.198x | -30.70% |
| 2022-12-31 | $6.01 Billion | $1.72 Billion | 0.286x | -15.95% |
| 2021-12-31 | $6.56 Billion | $2.23 Billion | 0.340x | +16.96% |
| 2020-12-31 | $6.89 Billion | $2.00 Billion | 0.291x | +34.90% |
| 2019-12-31 | $5.76 Billion | $1.24 Billion | 0.216x | -3.95% |
| 2018-12-31 | $5.34 Billion | $1.20 Billion | 0.225x | -3.78% |
| 2017-12-31 | $5.04 Billion | $1.18 Billion | 0.233x | +3.41% |
| 2016-12-31 | $4.74 Billion | $1.07 Billion | 0.226x | +33.26% |
| 2015-12-31 | $4.78 Billion | $810.00 Million | 0.169x | -21.82% |
| 2014-12-31 | $4.33 Billion | $938.00 Million | 0.217x | +32.00% |
| 2013-12-31 | $3.97 Billion | $652.00 Million | 0.164x | -42.13% |
| 2012-12-31 | $4.19 Billion | $1.19 Billion | 0.284x | +17.65% |
| 2011-12-31 | $3.71 Billion | $895.50 Million | 0.241x | -12.59% |
| 2010-12-31 | $4.05 Billion | $1.12 Billion | 0.276x | +10.91% |
| 2009-12-31 | $4.01 Billion | $997.40 Million | 0.249x | -15.69% |
| 2008-12-31 | $3.60 Billion | $1.06 Billion | 0.295x | +5.76% |
| 2007-12-31 | $3.32 Billion | $926.92 Million | 0.279x | -11.56% |
| 2006-12-31 | $3.02 Billion | $951.90 Million | 0.315x | +2.29% |
| 2005-12-31 | $2.76 Billion | $851.58 Million | 0.308x | -11.69% |
| 2004-12-31 | $2.29 Billion | $798.78 Million | 0.349x | +26.10% |
| 2003-12-31 | $2.39 Billion | $662.80 Million | 0.277x | -17.91% |
| 2002-12-31 | $1.77 Billion | $596.37 Million | 0.337x | -3.30% |
| 2001-12-31 | $1.34 Billion | $465.80 Million | 0.349x | -2.63% |
| 2000-12-31 | $1.03 Billion | $369.45 Million | 0.358x | +23.87% |
| 1999-12-31 | $863.10 Million | $249.50 Million | 0.289x | +16.10% |
| 1998-12-31 | $567.90 Million | $141.40 Million | 0.249x | -23.50% |
| 1997-12-31 | $541.70 Million | $176.30 Million | 0.325x | +298.14% |
| 1996-12-31 | $538.72 Million | $-88.49 Million | -0.164x | -- |
About Quest Diagnostics Incorporated
Quest Diagnostics Incorporated provides diagnostic testing and services in the United States and internationally. The company develops and delivers diagnostic information services, such as routine, non-routine and advanced clinical testing, anatomic pathology testing, and other diagnostic information services. It also provides diagnostic information services primarily under the Quest Diagnostics … Read more